LDN-212854,
LDN-212854,
1432597-26-6,
LDN212854,
BMP Inhibitor III,
LDN 212854,
5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline,
5-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline,
5-(6-(4-(1-Piperazinyl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline,
CHEMBL2385591,
SCHEMBL16025991,
AOB4039,
EX-A425,
SYN5196,
BDBM102618,
HMS3653M11,
BCP08633,
s7147,
ZINC96173500,
AKOS026750252,
CS-3212,
SB19484,
NCGC00386324-08,
AK547382,
AS-16555,
BC600479,
HY-15897,
FT-0768343,
SW220045-1,
Y1885,
VU0472597-1,
quinoline, 5-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-,
C25H22N6,
B3687,
A12821,
5-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline,
LDN-212854; 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyriMidin-3-yl]quinoline,